REACT Injections for Chronic Kidney Disease
A Long-Term Follow-Up Study of Participants Exposed to REACT
- Age
- 30 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- Prokidney · Industry
This trial is looking for people who have received a specific kidney treatment before. If selected, participants will receive up to two REACT injections into the same kidney over the course of several months to check the long-term safety of the treatment.
You may be able to join if
- I have received REACT in a previous trial for chronic kidney disease
- I completed an end of study visit in my previous trial
You may not be able to join if
- I did not receive REACT in a previous trial for chronic kidney disease
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
Loading trial locations…